Literature DB >> 9323068

Integrated mechanism for functional mitral regurgitation: leaflet restriction versus coapting force: in vitro studies.

S He1, A A Fontaine, E Schwammenthal, A P Yoganathan, R A Levine.   

Abstract

BACKGROUND: Functional mitral regurgitation in patients with ischemic or dilated ventricles has been related to competing factors: altered tension on the leaflets due to displacement of their papillary muscle and annular attachments, which restricts leaflet closure, versus global ventricular dysfunction with reduced transmitral pressure to close the leaflets. In vivo, however, geometric changes accompany dysfunction, making it difficult to study these factors independently. Functional mitral regurgitation also paradoxically decreases in midsystole, despite peak transmitral driving pressure, suggesting a change in the force balance acting to create a regurgitant orifice, with rising transmitral pressure counteracting forces that restrict leaflet closure. In vivo, this mechanism cannot be tested independently of annular contraction that could also reduce midsystolic regurgitation. METHODS AND
RESULTS: An in vitro model was developed that allows independent variation of papillary muscle position, annular size, and transmitral pressure, with direct regurgitant flow rate measurement, to test the hypothesis that functional mitral regurgitation reflects an altered balance of forces acting on the leaflets. Hemodynamic and echocardiographic measurements of excised porcine valves were made under physiological pressures and flows. Apical and posterolateral papillary muscle displacement caused decreased leaflet mobility and apical leaflet tethering or tenting with regurgitation, as seen clinically. It reproduced the clinically observed midsystolic decrease in regurgitant flow and orifice area as transmitral pressure increased. Tethering delayed valve closure, increased the early systolic regurgitant volume before complete coaptation, and decreased the duration of coaptation. Annular dilatation increased regurgitation for any papillary muscle position, creating clinically important regurgitation; conversely, increased transmitral pressure decreased regurgitant orifice area for any geometric configuration.
CONCLUSIONS: The clinically observed tented-leaflet configuration and dynamic regurgitant orifice area variation can be reproduced in vitro by altering the three-dimensional relationship of the annular and papillary muscle attachments of the valve so as to increase leaflet tension. Increased transmitral pressure acting to close the leaflets decreases the regurgitant orifice area. These results are consistent with a mechanism in which an altered balance of tethering versus coapting forces acting on the leaflets creates the regurgitant orifice.

Entities:  

Mesh:

Year:  1997        PMID: 9323068     DOI: 10.1161/01.cir.96.6.1826

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  60 in total

1.  Mechanistic insights into functional mitral regurgitation.

Authors:  Robert A Levine; Judy Hung; Yutaka Otsuji; Emmanuel Messas; Noah Liel-Cohen; Nadia Nathan; Mark D Handschumacher; J Luis Guerrero; Shengqiu He; Ajit P Yoganathan; Gus J Vlahakes
Journal:  Curr Cardiol Rep       Date:  2002-03       Impact factor: 2.931

2.  Reduced early diastolic inflow velocities in the antero-posterior transverse direction in the left ventricle of patients with dilated cardiomyopathy.

Authors:  S Fujimoto; Y Nakagawa; R Mizuno; S Nakanishi; K Dohi
Journal:  Int J Card Imaging       Date:  2000-02

Review 3.  Assessment of mitral regurgitation.

Authors:  T Irvine; X K Li; D J Sahn; A Kenny
Journal:  Heart       Date:  2002-11       Impact factor: 5.994

4.  Persistence of mitral regurgitation following ring annuloplasty: is the papillary muscle outside or inside the ring?

Authors:  Judy Hung; Jorge Solis; Mark D Handschumacher; J Luis Guerrero; Robert A Levine
Journal:  J Heart Valve Dis       Date:  2012-03

Review 5.  MitraClip: How Do We Reconcile the Inconsistent Findings of MITRA-FR and COAPT?

Authors:  Rina Mauricio; Dharam J Kumbhani
Journal:  Curr Cardiol Rep       Date:  2019-11-25       Impact factor: 2.931

Review 6.  Basic mechanisms of mitral regurgitation.

Authors:  Jacob P Dal-Bianco; Jonathan Beaudoin; Mark D Handschumacher; Robert A Levine
Journal:  Can J Cardiol       Date:  2014-07-02       Impact factor: 5.223

7.  Effect of mitral valve geometry on valve competence.

Authors:  Daniel M Espino; Duncan E T Shepherd; Keith G Buchan
Journal:  Heart Vessels       Date:  2007-03-23       Impact factor: 2.037

Review 8.  Effects of cardiac resynchronization therapy on ventricular remodeling.

Authors:  Hind W Rahmouni; James N Kirkpatrick; Martin G St John Sutton
Journal:  Curr Heart Fail Rep       Date:  2008-03

9.  Comparison of Transesophageal and Transthoracic Echocardiographic Measurements of Mechanism and Severity of Mitral Regurgitation in Ischemic Cardiomyopathy (from the Surgical Treatment of Ischemic Heart Failure Trial).

Authors:  Paul A Grayburn; Lilin She; Brad J Roberts; Krzysztof S Golba; Krzysztof Mokrzycki; Jaroslaw Drozdz; Alexander Cherniavsky; Roman Przybylski; Krzysztof Wrobel; Federico M Asch; Thomas A Holly; Haissam Haddad; Michael Yii; Gerald Maurer; Irving Kron; Hartzell Schaff; Eric J Velazquez; Jae K Oh
Journal:  Am J Cardiol       Date:  2015-06-25       Impact factor: 2.778

10.  A novel approach for reducing ischemic mitral regurgitation by injection of a polymer to reverse remodel and reposition displaced papillary muscles.

Authors:  Judy Hung; Jorge Solis; J Luis Guerrero; Gavin J C Braithwaite; Orhun K Muratoglu; Miguel Chaput; Leticia Fernandez-Friera; Mark D Handschumacher; Van J Wedeen; Stuart Houser; Gus J Vlahakes; Robert A Levine
Journal:  Circulation       Date:  2008-09-30       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.